minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.1.0 - Pre-STU 3 Development United States of America flag

minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International Clinical Interoperability Council. This is not an authorized publication; it is the continuous build for version 2.1.0). This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions

Table of Contents

...0 Table of Contents
...1 Home
...2 Patient Information
...3 Disease Characterization
...4 Assessment
...5 Genomics
...6 Treatments
...7 Outcomes
...8 Conformance Expectations
...9 Identifying In-Scope Patients
...10 Profile Conformance
...11 Terminology
...12 Data Dictionary
...13 Profiles
...14 Extensions
...15 Value Sets
...16 Code Systems
...17 Capability Statements
....18 Artifacts Summary
....18.1 mcode-receiver-cancer-conditions-then-patients
....18.2 mcode-receiver-patient-bundle
....18.3 mcode-receiver-patients-and-cancer-conditions
....18.4 mcode-receiver-patients-in-group
....18.5 mcode-receiver-patients-with-cancer-condition
....18.6 mcode-sender-cancer-conditions-then-patients
....18.7 mcode-sender-patient-bundle
....18.8 mcode-sender-patients-and-cancer-conditions
....18.9 mcode-sender-patients-in-group
....18.10 mcode-sender-patients-with-cancer-condition
....18.11 mcode-patient-everything
....18.12 Cancer Disease Status Profile
....18.13 Cancer Patient Profile
....18.14 Cancer-Related Medication Administration Profile
....18.15 Cancer-Related Medication Request Profile
....18.16 Cancer-Related Surgical Procedure Profile
....18.17 Cancer Stage Group Profile
....18.18 Comorbidities Profile
....18.19 ECOG Performance Status Profile
....18.20 Genomic Region Studied Profile
....18.21 Genomic Variant Profile
....18.22 Genomics Report Profile
....18.23 Human Specimen Profile
....18.24 Karnofsky Performance Status Profile
....18.25 mCODE Patient Bundle Profile
....18.26 mCODE Patient Group Profile
....18.27 Primary Cancer Condition Profile
....18.28 Radiotherapy Course Summary Profile
....18.29 Radiotherapy Volume Profile
....18.30 Secondary Cancer Condition Profile
....18.31 TNM Distant Metastases Category Profile
....18.32 TNM Primary Tumor Category Profile
....18.33 TNM Regional Nodes Category Profile
....18.34 TNM Stage Group Profile
....18.35 Tumor Profile
....18.36 Tumor Marker Test Profile
....18.37 Tumor Size Profile
....18.38 Body Structure Identifier Profile
....18.39 Body Location Qualifier Extension
....18.40 Cancer Disease Status Evidence Type Extension
....18.41 Histology-Morphology-Behavior Extension
....18.42 Laterality Qualifier Extension
....18.43 Procedure Intent Extension
....18.44 Radiotherapy Dose Delivered To Volume Extension
....18.45 Radiotherapy Modality Extension
....18.46 Radiotherapy Modality And Technique Extension
....18.47 Radiotherapy Number of Sessions Extension
....18.48 Radiotherapy Technique Extension
....18.49 Related Condition Extension
....18.50 Related Condition Absent Extension
....18.51 Treatment Termination Reason Extension
....18.52 Benign Neoplasm of Brain and CNS Disorder Value Set
....18.53 Body Location and Laterality Qualifier Value Set
....18.54 Body Location Qualifier Value Set
....18.55 Brachytherapy High Dose Rate Electronic Technique Value Set
....18.56 Brachytherapy High Dose Rate Technique Value Set
....18.57 Brachytherapy Low Dose Rate Temporary Radation Technique Value Set
....18.58 Brachytherapy Modality Value Set
....18.59 Brachytherapy Permanent Seeds Technique Value Set
....18.60 Brachytherapy Pulsed Dose Rate Technique Value Set
....18.61 Brachytherapy Radiopharmaceutical Technique Value Set
....18.62 Brachytherapy Technique Value Set
....18.63 Cancer Body Location Value Set
....18.64 Cancer Disease Status Evidence Type Value Set
....18.65 Cancer Disorder Value Set
....18.66 Cancer-Related Surgical Procedure Value Set
....18.67 Cancer Stage Group Value Set
....18.68 Cancer Staging Method Value Set
....18.69 Cancer Staging Type Value Set
....18.70 Carcinoma In-Situ Disorder Value Set
....18.71 Condition Status Trend Value Set
....18.72 Cytologic Evidence of Malignancy Value Set
....18.73 Histology Morphology Behavior Value Set
....18.74 Human Specimen Type Value Set
....18.75 Specific Diagnosis of Cancer Value Set
....18.76 Laterality Qualifier Value Set
....18.77 Melanoma In-Situ Disorder Value Set
....18.78 Primary Cancer Disorder Value Set
....18.79 Primary Malignant Neoplasm Disorder Value Set
....18.80 Procedure Intent Value Set
....18.81 Radiotherapy Modality Value Set
....18.82 Radiotherapy Technique Value Set
....18.83 Radiotherapy Treatment Location Qualifier Value Set
....18.84 Radiotherapy Treatment Location Value Set
....18.85 Radiotherapy Volume Type Value Set
....18.86 Secondary Cancer Disorder Value Set
....18.87 TNM Distant Metastases Maximum Value Set
....18.88 TNM Distant Metastases Category Value Set
....18.89 TNM Distant Metastases Staging Type Value Set
....18.90 TNM Primary Tumor Maximum Value Set
....18.91 TNM Primary Tumor Category Value Set
....18.92 TNM Primary Tumor Staging Type Value Set
....18.93 TNM Regional Nodes Maximum Value Set
....18.94 TNM Regional Nodes Category Value Set
....18.95 TNM Regional Nodes Staging Type Value Set
....18.96 TNM Stage Group Maximum Value Set
....18.97 TNM Stage Group Staging Type Value Set
....18.98 TNM Stage Group Value Set
....18.99 TNM Staging Method Value Set
....18.100 Carbon Ion Beam Technique Value Set
....18.101 Electron Beam Technique Value Set
....18.102 Teleradiotherapy Modality Value Set
....18.103 Neutron Beam Technique Value Set
....18.104 Photon Beam Technique Value Set
....18.105 Proton Beam Technique Value Set
....18.106 Teleradiotherapy Technique Value Set
....18.107 Treatment Termination Reason Value Set
....18.108 Tumor Marker Test Value Set
....18.109 Tumor Size Method Value Set
....18.110 Tumor Size Units Value Set
....18.111 Requested SNOMED Codes Code System
....18.112 Search by code:in in Conditions
....18.113 Search by _id in Patients with multipleOr
....18.114 binet-stage-group-A
....18.115 bodyheight-jenny-m-2018-03-06
....18.116 bodyweight-jenny-m-2018-03-16
....18.117 bodyweight-jenny-m-2018-04-22
....18.118 cancer-disease-status-improved
....18.119 cancer-disease-status-jenny-m
....18.120 cancer-patient-adam-everyman
....18.121 cancer-patient-eve-anyperson
....18.122 cancer-patient-jenny-m
....18.123 cancer-patient-john-anyperson
....18.124 cancer-related-comorbidities-jenny-m
....18.125 cancer-related-comorbidities-john-anyperson
....18.126 cancer-related-medication-admin-cyclophosphamide-jenny-m
....18.127 cancer-related-medication-admin-doxorubicin-jenny-m
....18.128 cancer-related-medication-admin-paclitaxel-jenny-m
....18.129 cancer-related-medication-request-anastrozole-jenny-m
....18.130 cancer-related-medication-request-cisplatin
....18.131 cancer-related-medication-request-cyclophosphamide-jenny-m
....18.132 cancer-related-medication-request-doxorubicin-jenny-m
....18.133 cancer-related-medication-request-gefitinib
....18.134 cancer-related-medication-request-paclitaxel-jenny-m
....18.135 cancer-related-surgical-procedure-jenny-m
....18.136 cancer-related-surgical-procedure-lobectomy
....18.137 ecog-performance-status-fully-active
....18.138 ecog-performance-status-jenny-m
....18.139 family-member-history-aunt-jenny-m
....18.140 family-member-history-sister-jenny-m
....18.141 family-member-history-uncle-jenny-m
....18.142 genomic-region-studied-jenny-m
....18.143 genomic-region-studied-stk11
....18.144 genomic-variant-fusion
....18.145 genomic-variant-germline-deletion
....18.146 genomic-variant-jenny-m
....18.147 genomic-variant-somatic-single-nucleotide
....18.148 genomics-report-jenny-m
....18.149 genomics-report-john-anyperson
....18.150 mCODE Patient Group Example
....18.151 human-specimen-left-breast-jenny-m
....18.152 human-specimen-lung
....18.153 jenny-m-chest-wall-lymph-nodes-treatment-volume
....18.154 jenny-m-chest-wall-treatment-volume
....18.155 john-anyperson-chf
....18.156 john-anyperson-treatment-volume
....18.157 karnofsky-performance-status-normal-activity
....18.158 lab-result-observation-hemoglobin
....18.159 mcode-patient-bundle-jenny-m
....18.160 observation-smoking-pack-years-jenny-m
....18.161 primary-cancer-condition-breast
....18.162 primary-cancer-condition-cll
....18.163 primary-cancer-condition-jenny-m
....18.164 primary-cancer-condition-nsclc
....18.165 radiotherapy-treatment-summary-chest-wall-jenny-m
....18.166 secondary-cancer-condition-brain-mets
....18.167 tnm-clinical-distant-metastases-category-cM0
....18.168 tnm-clinical-distant-metastases-category-jenny-m
....18.169 tnm-clinical-primary-tumor-category-cT3
....18.170 tnm-clinical-primary-tumor-category-jenny-m
....18.171 tnm-clinical-regional-nodes-category-cN3
....18.172 tnm-clinical-regional-nodes-category-jenny-m
....18.173 tnm-clinical-stage-group-3c
....18.174 tnm-clinical-stage-group-jenny-m
....18.175 tnm-pathologic-distant-metastases-category-jenny-m
....18.176 tnm-pathologic-primary-tumor-category-jenny-m
....18.177 tnm-pathologic-regional-nodes-category-jenny-m
....18.178 tnm-pathologic-stage-group-jenny-m
....18.179 tumor-lobular-carcinoma-left-breast
....18.180 tumor-marker-test-egf
....18.181 tumor-marker-test-er-jenny-m
....18.182 tumor-marker-test-her2-jenny-m
....18.183 tumor-marker-test-oncotype-dx-jenny-m
....18.184 tumor-marker-test-pr-jenny-m
....18.185 tumor-size-jenny-m
....18.186 tumor-size-pathology
....18.187 tumor-specimen-left-breast-jenny-m
....18.188 tumor-specimen-lobular-carcinoma-left-breast
....18.189 us-core-condition-anxiety-jenny-m
....18.190 us-core-condition-depression-jenny-m
....18.191 us-core-condition-hypertension-jenny-m
....18.192 us-core-diagnosticreport-lab-jenny-m
....18.193 us-core-observation-lab-neutrophils-jenny-m
....18.194 us-core-observation-lab-sentinel-nodes-jenny-m
....18.195 us-core-observation-lab-tumor-dcis-jenny-m
....18.196 us-core-observation-lab-tumor-grade-jenny-m
....18.197 us-core-observation-lab-tumor-invasion-jenny-m
....18.198 us-core-observation-lab-tumor-margins-jenny-m
....18.199 us-core-organization-bedrock-medicine
....18.200 us-core-organization-physician-services-inc
....18.201 us-core-practitioner-jane-radiotech
....18.202 us-core-practitioner-kyle-anydoc
....18.203 us-core-practitioner-mary-obgyn
....18.204 us-core-practitioner-nancy-oncology-nurse
....18.205 us-core-practitioner-owen-oncologist
....18.206 us-core-practitioner-peter-pathologist
....18.207 us-core-procedure-biopsy-jenny-m
....18.208 us-core-procedure-mammogram-jenny-m
....18.209 us-core-smokingstatus-jenny-m
...19 Basic Examples
...20 Extended Example
...21 Release Notes
...22 Glossary
...23 Download Specification